寒冷大气等离子体对高度质瘤的活性:一篇综述
Sophie Peeters1, Wi Jin Kim1, Amber Armellini1
1Department of Neurosurgery, David Geffen School of Medicine, University of California Los Angeles, 300 Stein Plaza, Suite 420, Los Angeles, CA, 90095, USA.
Journal of neuro-oncology
|October 29, 2025
概括
冷大气等离子体 (CAP) 通过选择性杀死癌细胞和调节免疫系统,显示出癌症治疗的前景. 进一步的研究正在探索其在神经瘤学中的应用,正在进行临床试验.
科学领域:
- 在瘤学瘤学.
- 等离子体物理学的物理学
- 生物医学工程 生物医学工程
背景情况:
- 冷大气等离子体 (CAP) 产生具有生物效应的反应性物种,如细胞死亡和免疫调节.
- 通过直接或间接的管理,CAP具有潜在的医疗应用,特别是在癌症治疗中.
- 它通过反应性氧和物种 (RONS),紫外线照射,热和电磁效应诱导癌细胞死亡,具有选择性毒性.
研究的目的:
- 审查关于CAP在神经瘤学中的应用的当前研究.
- 讨论与CAP在脑瘤治疗中的相关的体外和临床前发现.
- 简单地说,目前正在进行的临床试验中,CAP作为一种癌症疗法.
主要方法:
- 在神经瘤学中对CAP研究的文献综述.
- 对CAP对脑瘤的疗效进行了体外和临床前数据的分析.
- 确定正在进行的临床试验,研究CAP用于癌症治疗.
主要成果:
- 在包括质瘤在内的各种癌症中,CAP证明了选择性癌细胞死亡.
- 机制包括RONS介导的亡和通过物理效应的亡.
- CAP增强了抗瘤免疫力和瘤对全身疗法的反应能力.
结论:
- CAP是神经瘤学的一个有前途的工具,显示选择性瘤细胞死亡与最小的副作用.
- 需要进一步的研究和临床试验来确定CAP在脑癌治疗中的作用.
- 该综述总结了目前的证据和CAP在神经瘤学中的未来方向.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


